SK바이오사이언스
302440KOSPI· 의료용 물질 및 의약품 제조업35,150원-1,100 (-3.03%)전일 종가 2026-09-18
52주 위치
31,80061,30011%신고가 대비 -42.66%
- 시가총액
- 2.8조2조 7,577억
- PBR
- 1.58
- EPS(TTM)
- -1,081원
- BPS
- 22,257원
- 자사주비율
- 0.53%
- 결산월
- 12월
알림 만들기관심종목·메모·논지·저널은 로그인하면 사용 가능
| 항목 | 2021(별도) | 2022(별도) | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE | 22.18% | 7.35% | 1.30% | -3.07% | -3.20% |
| ROA | 16.83% | 5.78% | 1.12% | -2.13% | -1.94% |
| 영업이익률 | 51.05% | 25.26% | -3.24% | -51.74% | -18.96% |
| 순이익률 | 38.23% | 26.89% | 6.04% | -18.73% | -8.62% |
| 매출총이익률 | 61.39% | 52.46% | 38.50% | 11.58% | 11.66% |
| 부채비율 | 31.77% | 22.95% | 8.72% | 40.60% | 45.07% |
| 유동비율 | 399.56% | 468.05% | 1019.74% | 507.64% | 381.97% |
| 매출 성장률(YoY) | — | -50.84% | -19.10% | -27.59% | 143.46% |
| 영업이익 성장률(YoY) | — | -75.67% | -110.39% | — | — |
| 순이익 성장률(YoY) | — | -65.42% | -81.83% | -324.56% | — |
| FCF | 4,938억 | -1,971억 | -137억 | -2,924억 | -806억 |
| FCF 마진 | 53.16% | -43.17% | -3.70% | -109.30% | -12.37% |
| CAPEX/매출 | 4.60% | 15.82% | 11.64% | 61.45% | 28.11% |
| 항목 | 2021 3Q(별도) | 2021 4Q(별도) | 2022 1Q(별도) | 2022 2Q(별도) | 2022 3Q(별도) | 2022 4Q(별도) | 2023 1Q(별도) | 2023 2Q(별도) | 2023 3Q(별도) | 2023 4Q | 2024 1Q(별도) | 2024 2Q(별도) | 2024 3Q(별도) | 2024 4Q | 2025 1Q(별도) | 2025 2Q | 2025 3Q(별도) | 2025 4Q | 2026 1Q(별도) | 2026 2Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 5.38% | 11.49% | 1.70% | 2.73% | 1.33% | 1.68% | -0.82% | -0.91% | 2.85% | 0.16% | -0.77% | -0.63% | -1.27% | -0.24% | -0.46% | -0.93% | 1.21% | -3.25% | -1.71% | -1.01% |
| ROA | 3.98% | 8.72% | 1.39% | 2.20% | 1.03% | 1.32% | -0.69% | -0.77% | 2.44% | 0.13% | -0.67% | -0.55% | -1.10% | -0.18% | -0.39% | -0.70% | 1.01% | -2.01% | -1.36% | -0.48% |
| 영업이익률 | 45.47% | 56.32% | 27.27% | 44.25% | 23.46% | 6.47% | -139.38% | -131.60% | 26.55% | -11.03% | -123.68% | -72.28% | -63.47% | -33.41% | -62.97% | -23.10% | -37.46% | -9.16% | -87.70% | -10.11% |
| 순이익률 | 34.61% | 40.80% | 31.93% | 33.36% | 22.82% | 20.03% | -67.09% | -58.73% | 21.13% | 2.97% | -59.13% | -40.47% | -35.42% | -2.72% | -22.09% | -10.37% | 37.14% | -11.11% | -72.64% | -9.05% |
| 매출총이익률 | 59.48% | 62.66% | 54.89% | 62.30% | 61.27% | 35.54% | 4.30% | 24.48% | 45.50% | 32.44% | 24.23% | 67.72% | 2.96% | 3.58% | 10.03% | 7.35% | 25.48% | 10.15% | 9.42% | 26.67% |
| 부채비율 | 35.13% | 31.77% | 22.51% | 24.08% | 22.87% | 22.95% | 17.04% | 14.96% | 11.40% | 8.72% | 13.34% | 13.10% | 18.99% | 40.60% | 22.37% | 40.98% | 21.29% | 45.07% | 29.98% | 48.58% |
| 유동비율 | 369.81% | 399.56% | 547.48% | 470.12% | 489.07% | 468.05% | 592.54% | 651.63% | 789.84% | 1019.74% | 1033.75% | 1013.21% | 893.80% | 507.64% | 565.94% | 448.22% | 548.55% | 381.97% | 446.24% | 360.06% |
| 매출 성장률(YoY) | — | — | — | — | -58.77% | -68.88% | -76.35% | -80.85% | 154.61% | -35.42% | 8.13% | 1.13% | -73.41% | 73.11% | 62.61% | 504.46% | -7.33% | 235.00% | 12.71% | -3.80% |
| 영업이익 성장률(YoY) | — | — | — | — | -78.73% | -96.42% | -220.87% | -156.95% | 188.22% | -210.09% | — | — | -163.56% | — | — | — | — | — | — | — |
| 순이익 성장률(YoY) | — | — | — | — | -72.82% | -84.72% | -149.70% | -133.72% | 135.80% | -90.42% | — | — | -144.57% | -258.70% | — | — | — | — | — | — |
| FCF | 485억 | 3,196억 | -1,739억 | -590억 | -12.26억 | 370억 | -800억 | -1,140억 | 1,333억 | 470억 | -1,063억 | -479억 | -759억 | -623억 | 91.61억 | -589억 | -704억 | 396억 | -529억 | -510억 |
| FCF 마진 | 21.95% | 70.89% | -199.66% | -42.70% | -1.35% | 26.38% | -388.25% | -430.64% | 57.51% | 51.88% | -477.18% | -179.01% | -123.15% | -39.72% | 25.30% | -36.38% | -123.29% | 7.53% | -129.60% | -32.75% |
| CAPEX/매출 | 4.57% | 3.99% | 26.61% | 22.51% | 12.26% | 4.83% | 33.85% | 40.02% | 5.38% | 14.33% | 337.67% | 31.13% | 53.38% | 30.58% | 109.15% | 42.25% | 53.80% | 8.46% | 80.06% | 20.14% |
출처 DART 재무제표 원값으로 자체 계산· 갱신 2026-09-21 04:52· 연결·별도 혼합 · 산식은 항목 툴팁